This is not an argument against compounded medications
To overcome this limitation, scientists have developed GLP-1 receptor agonists (GLP-1 RAs), such as semaglutide, tilpotide, etc., which extend the half-life to the weekly formulation level through structural modification, achieving sustained regulation
Administering a GLP-1 agonist affects multiple organs simultaneously, explaining secondary benefits like reduced appetite, cardiovascular improvements, and kidney protection
Dosage of Glipiq 2mg Injection 1.5ml Use as prescribed by your doctor
Furthermore, an experimental study by Wang et al
Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): A randomized, double-blind, double-dummy, placebo-controlled, phase 3 trial